Cytokines and the acute respiratory distress syndrome (ARDS): A question of balance

Nature Medicine

Volumn 3, Issue 3, 1997, Pages 272-273

  Martin, Thomas R ^a  

^a Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOCORTICOID; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; HUMAN; NOTE; PRIORITY JOURNAL;

ACUTE DISEASE; CYTOKINES; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MACROPHAGE MIGRATION-INHIBITORY FACTORS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0031048963     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0397-272     Document Type: Note

References (16)

1. Donnelly, S.C. et al. Regulatory role for macrophage migration inhibitory factor (MIF) in the acute respiratory distress syndrome (ARDS). Nature Med. 3, 320-323 (1997).
2. Hudson, L.D., Milberg, J.A., Anardi, D. & Maunder, R.J. Clinical risks for development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151, 293-301 (1995).
3. Bachofen, A. & Weibel, E.R. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116, 589-615 (1977).
4. Steinberg, K., Maunder, R.M., Milberg, J., Martin, T.R. & Hudson, L.D. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150, 113-122 (1994).
5. Milberg, J.A., Davis, D.R., Steinberg, K.P. & Hudson, L.D. Improved survival of patients with acute respiratory distress syndrome (ARDS). JAMA 273, 306-309 (1995).
6. Pittet, J.F., Mackersie, R., Martin, T.R. & Matthay, M.A. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. (in the press).
7. Donnelly, S.C. et al. Interleukin-8 and development of adult respiratory distress syndrome in atrisk groups. Lancet 341, 643-647 (1993).
8. Goodman, R.B. et al. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154, 602-611 (1996).
9. Pugin, J., Ricou, B., Steinberg, K.P., Suter, P.M. & Martin, T.R. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1β. Am. J. Respir. Crit. Care Med. 153, 1850-1856 (1996).
10. Donnelly, S.C. et al. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 125, 191-196 (1996).
11. Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 365, 756-759 (1993).
12. Calandra, T. et al. MIF is a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71 (1995).
13. Bacher, M. et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 150, 235-246 (1997).
14. Bernard, G.R. et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. New Engl. J. Med. 317, 1365-1370 (1987).
15. Meduri, G.U. et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Chest 105, 1516-1527 (1994).
16. McHugh, L. et al. Recovery of function in survivors of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150, 90-94 (1994).